Shots:

• The companies collaborated to expand the deployment of AI to other Medipath network labs. The implementation will help Medipath pathologists with increased diagnostic accuracy & efficiency and includes new AI-powered capabilities for diagnosing a variety of tissue types
• Ibex's solutions will be made available by Medipath to all sites in France. The Galen platform will be used by Medipath pathologists to assist in decision-making during the first diagnosis of breast, prostate, and stomach biopsies
• The Galen platform helps to improve the accuracy of cancer diagnosis, reduce the turnaround time, boost productivity & improve the user experience for pathologists. Galen showed good outcomes in multiple clinical studies on multiple tissue types & diagnostic workflows

Ref: PR Newswire | Image: Ibex